The effects of carmeda bioactive surface on human blood components during simulated extracorporeal circulation
Authors:
- Carol A. FisherCFCarol A. Fisher
- Elizabeth R. LivingstonELElizabeth R. Livingston
- Nina StenachNSNina Stenach
- Steven J. FishmanSFSteven J. Fishman
- Valluvan JeevanandamVJValluvan Jeevanandam
- V.Paul AddonizioVAV.Paul Addonizio
- 1 May 1996
- journal article
- research article
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 111 (5) , 1073-1084
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Safe use of heparin-coated bypass circuits incorporating a pump-oxygenatorThe Annals of Thoracic Surgery, 1994
- Clinical cardiopulmonary bypass without systemic anticoagulationThe Annals of Thoracic Surgery, 1993
- AnticoagulationThe Annals of Thoracic Surgery, 1993
- Performance Characteristics of Centrifugal Pumps with Heparin Surface CoatingThe Thoracic and Cardiovascular Surgeon, 1990
- Platelets and extracorporeal circulationBiomaterials, 1982
- Complement Activation during Cardiopulmonary BypassNew England Journal of Medicine, 1981
- Structural Determinants of the Capacity of Heparin to Inhibit the Formation of the Human Amplification C3 ConvertaseJournal of Clinical Investigation, 1981
- Detection of thromboxane B2 in peripheral blood of patients with Prinzmetal's anginaProstaglandins and Medicine, 1979
- Studies on the Liberation of β‐Thromboglobulin from Human Platelets in VitroBritish Journal of Haematology, 1976
- Clofibrate Reversal of Platelet Hypersensitivity in HyperbetalipoproteinemiaCirculation, 1974